50% oxygen administration for 30 minutes via a full-face continuous positive airway pressure mask without positive airway pressure. Followed by a 30 minute washout period.

7 trials

Sponsors

Janine Pilcher, Medical Research Institute of New Zealand

Unknown Phase

High Concentration Oxygen in Bronchiectasis

CompletedACTRN12612000356864

Start: 2012-06-12End: 2013-12-04Target: 24Updated: 2020-01-13

High Concentration Oxygen in Fibrotic Lung Disease

SuspendedACTRN12612000381886

Start: 2013-07-24Target: 24Updated: 2020-01-13

High Concentration Oxygen in Neuromuscular Disease

CompletedACTRN12612000393853

Start: 2012-09-13End: 2015-01-05Target: 24Updated: 2020-01-13

High concentration oxygen in Chronic Obstructive Pulmonary Disease (COPD)

CompletedACTRN12614000361606

Medical Research Institute of New Zealand

Start: 2014-06-10End: 2015-01-21Target: 24Updated: 2020-01-13

High Concentration Oxygen in Bronchiectasis or Cystic Fibrosis: Study 2

CompletedACTRN12615000971538

Start: 2015-10-14End: 2016-07-21Target: 24Updated: 2021-06-14

High Concentration Oxygen in Neuromuscular Disease: Study 2

CompletedACTRN12615000970549

Start: 2015-10-13End: 2017-05-30Target: 24Updated: 2021-06-14

High concentration oxygen in Chronic Obstructive Pulmonary Disease (COPD): Study 2

CompletedACTRN12615001056583

Medical Research Institute of New Zealand

Start: 2016-01-28End: 2017-05-18Target: 24Updated: 2021-06-14

Related Papers

The effect of 50% oxygen on PtCO2 in patients with stable COPD, bronchiectasis, and neuromuscular disease or kyphoscoliosis: randomised cross-over trials

BMC Pulmonary Medicine2020-05-07